Embla Medical hf.

Equities

EMBLA

IS0000000040

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2024-07-12 am EDT			5-day change	1st Jan Change
28.7 ^DKK	-1.37%		-2.38%	+4.55%

Apr. 23	Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024
Apr. 23	Embla Medical hf. Provides Earnings Guidance for the Year 2024	CI

Embla Medical hf: Conference call details for Q2 2024

July 09, 2024 at 01:01 am EDT

9 July 2024

Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q2 2024 Interim Report on 23 July 2024 at 7:00 CET. A conference call will be hosted on the same date at 9:00 CET / 7:00 GMT / 3:00am EST.

The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly results and will be held in English.

Slides used in the presentation will be made available on the company website at the following link: http://www.emblamedical.com/investors

The conference call webcast can be accessed through following link: Embla Medical Q2 2024 webcast

To actively participate in the Q&A session during the call please use following link for dial in options Registration form for Conference Call Q&A

Financial calendar and events 2024

23 July 2024 Q2 2024 Interim Report

Q2 virtual road show

Presentation of Q2 2024 (HC Andersen Capital)

26 Aug 2024 Økonomisk Ugebrev Life Science Conference, Copenhagen

2 Sep 2024 Road Show, Copenhagen (Danske Bank)

5 Sep 2024 Goldman Sachs Medtech and Healthcare Services Conference, London

17 Sep 2024 HC Andersen Capital Seminar, Copenhagen

19 Sep 2024 Pareto Healthcare Conference Stockholm

23 Oct 2024 Q3 2024 Interim Report

26 Nov 2024 DNB Nordic Healthcare Conference, Oslo

27 Nov 2024 Danske Bank Winter Seminar, Copenhagen

If you wish to receive Embla Medical press releases by e-mail, please register here

For further information please contact

Klaus Sindahl
Head of Investor Relations
E: ksindahl@emblamedical.com
M: +45 5363 0134

About Embla Medical

Embla Medical (Nasdaq Copenhagen: EMBLA) is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. Home to several leading brands, Embla Medical is dedicated to improving people`s mobility by providing prosthetics, neuro orthotics, bracing & supports and patient care through a global network of orthotic & prosthetic facilities. Embla Medical is committed to sustainable business practices renowned for positively impacting people`s health and well-being.

https://news.cision.com/embla-medical-hf-/r/embla-medical-hf--conference-call-details-for-q2-2024,c4012749

https://mb.cision.com/Main/18404/4012749/2907195.pdf

Latest news about Embla Medical hf.

Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024	Apr. 23
Embla Medical hf. Provides Earnings Guidance for the Year 2024	Apr. 23	CI
Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Össur hf. will Change its Name to Embla Medical hf	Apr. 08	CI
Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee	Mar. 13	CI
Össur hf Establishes New Parent Organization to Be Named Embla Medical	Feb. 21	CI
Transcript : Össur hf., Q4 2023 Earnings Call, Jan 30, 2024	Jan. 30
Össur hf. Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 30	CI
Össur hf. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Jan. 30	CI
Össur hf. Provides Earnings Guidance for the Year 2024	Jan. 30	CI
Iceland's Össur to Purchase Fior & Gentz	Jan. 16	MT
Transcript : Fior & Gentz Gesellschaft Für Entwicklung Und Vertrieb Von Orthopädietechnischen Systemen Mbh, Össur hf. - M&A Call	Jan. 16
Össur hf. agreed to acquire Fior & Gentz Gesellschaft Für Entwicklung Und Vertrieb Von Orthopädietechnischen Systemen Mbh for ?120 million.	Jan. 15	CI
Transcript : Össur hf., Q3 2023 Earnings Call, Oct 24, 2023	23-10-24
Össur hf. Reaffirms Financial Guidance for the Year 2023	23-10-24	CI
Össur hf. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-24	CI
Transcript : Össur hf., Q2 2023 Earnings Call, Jul 25, 2023	23-07-25
Össur hf. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-25	CI
Össur hf. Announces Executive Changes	23-06-15	CI
Össur hf. Provides Earnings Guidance for the Year 2023	23-04-25	CI
Transcript : Ã–ssur hf., Q1 2023 Earnings Call, Apr 25, 2023	23-04-25
Össur hf. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Össur to Seek Acquisitions	23-03-30	CI
Transcript : Össur hf. - Analyst/Investor Day	23-03-30
Transcript : Össur hf., Q4 2022 Earnings Call, Jan 31, 2023	23-01-31

Chart Embla Medical hf.

Duration

Period

More charts

Company Profile

Embla Medical hf, formerly Ossur hf, is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company's business activities are divided into three business segment: The Prosthetics, its product portfolio includes a range of lower and upper limb prosthetic components; The Bracing & Supports, which offers the Unloader One range of knee braces that relieve pain from knee osteoarthritis, as well as the Unloader Hip which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip; and The Patient Care, which operates a network of Patient Care clinics around the world, with each one catering to individual patients and their needs.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-23 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Embla Medical hf.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

28.7 DKK

Average target price

34.72 DKK

Spread / Average Target

+20.98%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
EMBLA MEDICAL HF.	+4.55%	1.79B
SONOVA HOLDING AG	+1.06%	18.49B
COCHLEAR LIMITED	+9.82%	14.59B
DEMANT A/S	+2.30%	9.64B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-27.45%	1.81B
ANGELALIGN TECHNOLOGY INC.	+7.16%	1.31B
MODERN DENTAL GROUP LIMITED	-4.42%	498M
ANGEL ROBOTICS CO., LTD.	0.00%	355M
DELCATH SYSTEMS, INC.	+93.99%	224M
INTEGRUM AB	+22.23%	103M

Medical Prosthetics